UK Life Science 'Needs Manufacturing Incentives, NHS Access' After Brexit
Executive Summary
MSD's R&D head Roger Perlmutter and Sir John Bell tell Scrip the UK government needs to offer better manufacturing incentives to the life science sector and also encourage more efficient drug innovation there.